CognoSpeak: AI tool uses speech technology to quickly assess dementia risk

FHS
June 29, 2023
3:11 am

A new AI tool that could help doctors assess the early signs of dementia and Alzheimer’s more quickly and efficiently, has been developed by researchers at the University of Sheffield.

One in Nine Kids Have ADHD; Placebo Response in Trials; Befriending Former Patients

Approximately one in nine U.S. children ever received an attention deficit-hyperactivity disorder (ADHD) diagnosis, CDC researchers reported. (Journal of Clinical Child & Adolescent Psychology) The

May 30, 2024

Syndax enters funding agreement with Royalty Pharma for Niktimvo

Niktimvo, an anti-CSF-1R antibody, has received approval in the US for treating chronic GVHD. Credit: Andrei_R/Shutterstock. Syndax Pharmaceuticals has entered a synthetic royalty funding agreement

November 5, 2024

A conversation with researcher Kevin Esvelt on the urgency of improving biosecurity measures

If you ask a chatbot how to cause a pandemic, it will suggest the 1918 influenza virus, according to researcher Kevin Esvelt. It will even

May 22, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.